Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
about
TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathwayRegulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cellsToll-like Receptors in Ovarian Cancer as Targets for ImmunotherapiesMechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infectionToll-like receptors in pathophysiology of liver diseasesToll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosisMyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.Pathogen recognition receptors, cancer and inflammation in the gut.Tumor-associated macrophages contribute to tumor progression in ovarian cancer.Revisiting the hallmarks of cancer.The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.Anti-inflammatory and anti-insulin resistance activities of aqueous extract from Anoectochilus burmannicus.TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells.Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer.Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.Enhanced stimulation of anti-ovarian cancer CD8(+) T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen.Support Vector Machine classifier for estrogen receptor positive and negative early-onset breast cancer.Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.Ovarian cancer stem cells and inflammationActivation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma.Altered expression of hypoxia-inducible factor-1α (HIF-1α) and its regulatory genes in gastric cancer tissuesSystemic inflammation impairs respiratory chemoreflexes and plasticity.Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptomsPrognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells.Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosisTLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrenceNeutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress.Links between Toll-like receptor 4 and breast cancerToll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology.Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potentialDistinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotypeTriggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.TLR4 is a novel determinant of the response to paclitaxel in breast cancerInflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4The role of microRNAs in ovarian cancer initiation and progression.
P2860
Q24336598-38519837-5DB3-4720-90B9-5557CE482EC5Q24618984-DE2BB15C-1078-4F45-9200-D138F7C5531DQ26861234-C297D13D-4502-4EC0-87ED-1A19C460CBE2Q27002467-98B90011-157E-4DA9-B841-186A4AAE5722Q28070077-93A84B84-A91E-4509-B655-A61C4BDF5CCEQ28538422-1F4215FA-762D-4B5E-849A-B72C29951029Q33302912-AC5356DF-910A-4D67-BC7D-FA343AAC6A43Q33579661-E6977D77-84C0-43CC-A226-1F3DFE668888Q33680511-A212ED50-1C35-4E84-B6A5-057721F261FAQ33718878-852B73E4-B2A8-4E2E-9E51-DF0A9C226EA7Q33732986-C895E281-1719-4085-BFDE-B5F8973FBEF3Q33737469-6006ADB0-7AD1-4EB6-860F-A4E077DAA7EFQ33740024-EBB3FC50-A068-425E-AEE1-8BA7B72C1264Q33927452-A43F3CCE-9A4D-4AE4-934F-E19FE54DB0A3Q34424820-AD618387-FAF2-451F-B63E-3EAC9DCD0DEEQ34616118-C8DB70BF-7838-4551-9834-D8FD82E62DBBQ34673706-668F81D4-CBE5-4428-AC42-6E2B1F886675Q34675920-4D6C01A4-9EF7-4B4B-9BBC-EA94C368FB07Q34860928-C2FD5955-EEFC-414A-8A60-69DC91DCD445Q34872901-1AD74F6F-15EE-47CB-9C2A-E8C463994A9BQ34994700-851BAA9E-15C9-43B9-8682-39A9C40AD4A0Q35001138-EE99DC53-FBD5-4C7E-BDEA-AEFAD6ABFD92Q35127878-7D4D17C3-0B42-4F19-BA56-515529B6789FQ35187699-4D4F713A-59D9-48A1-86CF-BB65386BB52EQ35212454-3F8188EE-9CEC-428F-8670-83FD36EB4651Q35832150-58FC7A9C-CF0A-4494-8102-E4DE429A0F15Q35863748-EFCB9E6F-025E-41FE-96CD-B27A26004C09Q36222691-246F1CE2-9AAA-428B-AFAE-C6E8F2472631Q36394694-8F48DCC1-016F-43D8-B685-6D3DA6E5670AQ36654413-249E23EA-A6F9-4B18-BADD-C2FDA6B5C7D0Q36693228-56CD6839-B9B3-4C67-9348-6D9890B51318Q36694906-BDC57E96-940D-412E-9E1F-83BBDF076E39Q36860597-97DC66A4-10A0-476E-A888-B8DDEE300CCFQ36989636-B6004632-D424-4FA1-A3A8-F4CD53617498Q36999077-E039CD3B-9B79-45F7-90FB-16744C647033Q37002943-D61B9320-DAC6-4712-95DE-39A307603485Q37051030-AB9CEE5B-D1EF-4BF8-BFEF-1E947CA6E991Q37093119-E0E3218D-559B-41CF-9B20-D4130DA29755Q37232937-C8567F36-03F2-4915-8650-D8EEA89E7F03Q37293916-67B9FCAB-3E8F-4E29-93B7-6D2754E3FD41
P2860
Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inflammation, cancer and chemo ...... ke receptor signaling pathway.
@ast
Inflammation, cancer and chemo ...... ke receptor signaling pathway.
@en
type
label
Inflammation, cancer and chemo ...... ke receptor signaling pathway.
@ast
Inflammation, cancer and chemo ...... ke receptor signaling pathway.
@en
prefLabel
Inflammation, cancer and chemo ...... ke receptor signaling pathway.
@ast
Inflammation, cancer and chemo ...... ke receptor signaling pathway.
@en
P2093
P2860
P1476
Inflammation, cancer and chemo ...... ke receptor signaling pathway.
@en
P2093
Ayesha B Alvero
Dan-Arin Silasi
P2860
P304
P356
10.1111/J.1600-0897.2006.00441.X
P577
2007-02-01T00:00:00Z